Retro Biosciences, a startup with a goal of adding 10 years onto the average human life span, has received $180 million from Sam Altman, CEO of OpenAI. Altman, a prominent figure in Silicon Valley and an early investor in companies such as Stripe and Airbnb, has poured his liquid net worth into the anti-aging and fusion power startups focusing on extended lifespan and limitless energy. Retro Biosciences aims to stall or even reverse aging, and Altman is betting that the companys work has the potential to significantly alter society in profound ways.
